Trial intelligence / Profile preview

Icatibant in Treatment of Idiopathic Angioedema

2010-019037-10Phase 2Active

Sponsor
Luigi Sacco University Hospital
Start
Dec 2010
Modality
Peptides
Countries
1
01

Overview

Phase 2 trial of icatibant in idiopathic angioedema (2 arms), sponsored by Luigi Sacco University Hospital. Primary endpoint: Time to onset of symptom relief. Started Dec 2010; status: active.

02

Drugs

icatibant
03

Conditions

idiopathic angioedema

Beyond the preview

Go deeper on 2010-019037-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019037-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call